Karin Mölling (often cited in English as Moelling; born 7 April 1943 in Meldorf, Dithmarschen, Germany) is a German virologist whose research focused on retroviruses, particularly human immunodeficiency virus (HIV).
She is retired but retains affiliations with the University of Zurich and with the Max Planck Institute for Molecular Genetics in Berlin.
[2] During her academic career Mölling also co-founded several biotechnology companies, was involved in a clinical trial for an HIV vaccine candidate,[3] and supervised around 100 master's and PhD students.
[1] Mölling's research interests focused primarily on retroviruses, particular human immunodeficiency virus (HIV), on which she began work as a graduate student.
[3] She has also worked on oncogenes, leading to the isolation of the Myc transcription factor protein;[6] on virus diagnostics;[1] and more recently on the evolutionary history of retroviruses and retrotransposons.